Innovation Update

Dividend.com: Morning Playbook

Stock quotes in this article: ERTS , WFMI , GRMN , ICE , CCE , BYD , XTO , CVS  

It's a flat start to Wednesday's trading day, but there are lots of names in the news. Let's take a look.

Story Stocks

Electronic Arts(ERTS Quote): Shares are slightly lower following 10th consecutive quarterly loss.

Whole Foods(WFMI Quote): Shares are spiking higher after beating estimates and raising guidance.

Jones Lang Lasalle(JLL Quote): Shares are slightly lower following Q2 results.

Ctrip(CTRP Quote): Shares are lower after company matched analyst estimates.

BMC Software(BMC Quote): Shares are lower despite company raising guidance.

Procter & Gamble(PG Quote): Stock is lower after company reports profit fall.

Garmin(GRMN Quote): Shares are spiking following earnings results.

Marsh & McLennan(MMC Quote): Stock is slightly higher following second-quarter loss.

Devon Energy(DVN Quote): Shares are up after company beats analyst estimates.

Foster Wheeler(FWLT Quote): Shares are up despite 24% profit drop.

CF Industries(CF Quote): Stock is higher after announcing it will raise its offer for Terra Industries(TRA Quote).

Polo Ralph Lauren(RL Quote): Shares are higher after company reaffirms guidance.

Transocean Offshore(RIG Quote): Stock is lower following 24% profit drop in the second quarter.

Boyd Gaming(BYD Quote): Shares edge higher despite profit and revenue falling.

Dean Foods(DF Quote): Stock is slightly lower after raising guidance to match current estimates.

XTO Energy(XTO Quote): Shares are higher after company raises production guidance.

Agrium(AGU Quote): Shares are up despite profit falling 42%.

Cephalon(CEPH Quote): Stock is lower after Q3 revenue guidance is below current analyst estimates.

Upgrades to Watch

CVS Caremark(CVS Quote): Goldman Sachs raises estimates and target price to $40.

Brinker International(EAT Quote): UBS raises stock rating to a buy. $22 price target.

Chesapeake Energy(CHK Quote): Goldman Sachs raises estimates and price target to $27.

Valeant Pharmaceuticals(VRX Quote): Merrill Lynch/Bank of America raises price target to $21.

  • Loading Comments...
  •  
< Previous
1 2

SHARE:

  • email
  • print
  • comment
  • digg
  • delicious
  • linkedin

Recent Comments





Connect with TheStreet

Dow Jones S&P 500 NASDAQ 10-Year Note
10,344.84 1,095.63 2,144.60 32.01
Oil *
78.55
UP
34.92
UP
4.14
UP
6.16
DOWN
0.30
10 Yr
3.20%
SPDR Gold
115.65
+0.34%
+0.38%
+0.29%
-0.93%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services